L&G Healthcare Technology & Innovation UCITS ETF USD Acc

L&G Healthcare Technology & Innovation UCITS ETF USD Acc is an accumulating exchange-traded fund that tracks the ROBO Global Healthcare Technology and Innovation Index. It provides targeted exposure to global companies at the forefront of healthcare innovation, including those in biotechnology, pharmaceuticals, medical devices, diagnostic tools, and healthcare services. These firms focus on breakthrough treatments, cutting-edge technologies, and solutions addressing critical health challenges, with heavy emphasis on North America (around 72%) and sectors like industrials, healthcare, and technology. Managed by Legal & General Investment Management, one of Europe's largest asset managers, the ETF features a total expense ratio of 0.49% and reinvests dividends to support compound growth. Notable holdings include Moderna Inc., Guardant Health Inc., and Thermo Fisher Scientific Inc., representing key innovators in genomics, diagnostics, and life sciences. Launched in 2019 and domiciled in Ireland, it offers diversified access to the evolving healthcare technology landscape, appealing to those tracking advancements in medical R&D and patient outcomes.